Trust, The fragile foundation of contemporary biomedical research.
暂无分享,去创建一个
N. Kass | R. Faden | M. Schoch-Spana | R. Faden | R Faden | N E Kass | J Sugarman | M Schoch-Spana | J. Sugarman | Nancy E. Kass | Jeremy Sugarman | Monica Schoch-Spana
[1] J. H. Jones. The Tuskegee legacy. AIDS and the black community. , 1992, The Hastings Center report.
[2] I. Tannock,et al. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Rodenhuis,et al. Patient motivation and informed consent in a phase I study of an anticancer agent. , 1984, European journal of cancer & clinical oncology.
[4] M. Ratain,et al. Perceptions of cancer patients and their physicians involved in phase I trials. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Holland,et al. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] E. Lusk,et al. Attitudes toward clinical trials among patients and the public. , 1982, JAMA.
[7] S. Bok. Shading the Truth in Seeking Informed Consent for Research Purposes , 1995, Kennedy Institute of Ethics journal.
[8] A. Baier. Trust and Antitrust , 1986, Ethics.